Health Canada authorizes second bivalent COVID-19 booster targeting the Omicron BA.4/5 variants
OTTAWA, ON, Nov. 3, 2022 /CNW/ - Today, Health Canada authorized an adapted version of the Moderna Spikevax COVID-19 vaccine that targets the Omicron BA.4/BA.5 subvariants.
- OTTAWA, ON, Nov. 3, 2022 /CNW/ - Today, Health Canada authorized an adapted version of the Moderna Spikevax COVID-19 vaccine that targets the Omicron BA.4/BA.5 subvariants.
- After a thorough and independent scientific review of the evidence, Health Canada has determined that the bivalent Moderna Spikevax booster is safe and effective.
- Health Canada has placed terms and conditions on the authorization requiring Moderna to continue providing information to Health Canada on the safety and efficacy of the bivalent vaccine.
- Health Canada and the Public Health Agency of Canada will continue to closely monitor the safety of this vaccine in Canada and internationally, and will take action if any safety concerns are identified.